Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1722879
PUBLISHER: IMARC | PRODUCT CODE: 1722879
Anti-venom Market Size, Share, Trends and Forecast by Species, Anti-Venom Type, Mode of Action, End User, and Region, 2025-2033
PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global anti-venom market size was valued at USD 1,240.1 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,059.7 Million by 2033, exhibiting a CAGR of 5.8% during 2025-2033. North America currently dominates the market, holding a significant market share of over 37.8% in 2024. The rising incidences of snake bites and scorpion stings, the implementation of favorable government initiatives, and ongoing innovations in the industry represent some of the key factors driving the market toward growth.
Anti-venom, also known as venom antiserum, refers to a type of medication used to treat the effects of venomous bites or stings from animals, including snakes, spiders, scorpions, and certain marine creatures such as jellyfish or cone snails. It is obtained by extracting venom from the offending animal and then injecting small amounts of the venom into animals, such as horses, sheep, or goats, whose immune systems produce antibodies that are harvested and purified to create anti-venom. Anti-venom neutralizes the toxins and counteracts the effects of the venom, preventing them from causing life-threatening complications such as respiratory failure or organ damage. It is extensively adopted across the globe in treating venomous bites and stings, depending on their history, examination, and geographic, clinical, and pathologic factors.
Anti-Venom Market Trends:
The rise in cases of venomous bites and stings across the world, particularly in rural and tropical regions and among agricultural workers and hunters, represents one of the prime factors driving the market growth. Besides this, the escalating consumer awareness of the importance of snake bite prevention and easy product availability at an affordable price is creating a favorable outlook for the market. Moreover, the implementation of numerous government initiatives to combat snake bites, such as education and training programs, and intensive investments in research and development (R&D) activities of new anti-venom products are contributing to the market growth. In addition to this, with the rising demand for animal-based protein, there is an increase in the number of livestock and other animals at risk of snake bites, which, in turn, is presenting remunerative growth opportunities for the market. Concurrent with this, the rising popularity of traveling and exploring exotic destinations, such as islands, deserts, jungles, and safaris, that puts tourists at risk of snake bites and other venomous animal encounters is acting as another significant growth-inducing factor. Furthermore, numerous technological advancements in the biotechnology and healthcare industries and ongoing innovative improvements in manufacturing technology, allowing for the production of more effective and efficient anti-venom products, are positively impacting the market growth. Apart from this, the launch of various rapid snake venom detection kits, which utilize a rapid enzyme immunoassay to detect and identify snake venom through samples taken from bite sites, urine, plasma, blood, or other tissues and body fluids, is propelling the market forward.
Key Market Segmentation:
Species Insights:
- Snake
- Scorpion
- Spider
- Others
Anti-venom Type Insights:
- Polyvalent Anti-venom
- Monovalent Anti-venom
Mode of Action Insights:
- Cytotoxic
- Neurotoxic
- Haemotoxic
- Cardiotoxic
- Myotoxic
- Others
End User Insights:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
- The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for anti-venom. Some of the factors driving the North America anti-venom market included the increasing incidence of snake bites, the introduction of numerous favorable government initiatives, and the thriving travel and tourism sector.
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the global anti-venom market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, CSL Limited, Haffkine Bio-Pharmaceutical Corporation Limited, Incepta Pharmaceuticals Limited, Merck & Co. Inc., Merck KGaA, MicroPharm Limited, Pfizer Inc., and Rare Disease Therapeutics Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1.What is anti-venom?
- 2.How big is the anti-venom market?
- 3.What is the expected growth rate of the global anti-venom market during 2025-2033?
- 4.What are the key factors driving the global anti-venom market?
- 5.What is the leading segment of the global anti-venom market based on the species?
- 6.What is the leading segment of the global anti-venom market based on anti-venom type?
- 7.What is the leading segment of the global anti-venom market based on the mode of action?
- 8.What is the leading segment of the global anti-venom market based on the end user?
- 9.What are the key regions in the global anti-venom market?
- 10.Who are the key players/companies in the global anti-venom market?
Product Code: SR112025A5147
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Anti-venom Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Species
- 6.1 Snake
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Scorpion
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Spider
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Anti-venom Type
- 7.1 Polyvalent Anti-venom
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Monovalent Anti-venom
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Mode of Action
- 8.1 Cytotoxic
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Neurotoxic
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Haemotoxic
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Cardiotoxic
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Myotoxic
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Ambulatory Surgical Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Bharat Serums and Vaccines Limited (BSV)
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Boehringer Ingelheim International GmbH
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Boston Scientific Corporation
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 CSL Limited
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Haffkine Bio-Pharmaceutical Corporation Limited
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Incepta Pharmaceuticals Limited
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Merck & Co. Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Merck KGaA
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 MicroPharm Limited
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Pfizer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Rare Disease Therapeutics Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.1 Bharat Serums and Vaccines Limited (BSV)
Product Code: SR112025A5147
List of Figures
- Figure 1: Global: Anti-venom Market: Major Drivers and Challenges
- Figure 2: Global: Anti-venom Market: Sales Value (in Million USD), 2019-2024
- Figure 3: Global: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 4: Global: Anti-venom Market: Breakup by Species (in %), 2024
- Figure 5: Global: Anti-venom Market: Breakup by Anti-venom Type (in %), 2024
- Figure 6: Global: Anti-venom Market: Breakup by Mode of Action (in %), 2024
- Figure 7: Global: Anti-venom Market: Breakup by End User (in %), 2024
- Figure 8: Global: Anti-venom Market: Breakup by Region (in %), 2024
- Figure 9: Global: Anti-venom (Snake) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Anti-venom (Snake) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Anti-venom (Scorpion) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Anti-venom (Scorpion) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Anti-venom (Spider) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Anti-venom (Spider) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Anti-venom (Other Species) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Anti-venom (Other Species) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Anti-venom (Polyvalent Anti-venom) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Anti-venom (Polyvalent Anti-venom) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Anti-venom (Monovalent Anti-venom) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Anti-venom (Monovalent Anti-venom) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Anti-venom (Cytotoxic) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Anti-venom (Cytotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Anti-venom (Neurotoxic) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Anti-venom (Neurotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Anti-venom (Haemotoxic) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Anti-venom (Haemotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Anti-venom (Cardiotoxic) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Anti-venom (Cardiotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Global: Anti-venom (Myotoxic) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Global: Anti-venom (Myotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Global: Anti-venom (Other Mode of Actions) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Global: Anti-venom (Other Mode of Actions) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: Global: Anti-venom (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: Global: Anti-venom (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: Global: Anti-venom (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: Global: Anti-venom (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: Global: Anti-venom (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: Global: Anti-venom (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: North America: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: North America: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: United States: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: United States: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: Canada: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: Canada: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Asia-Pacific: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Asia-Pacific: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: China: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: China: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: Japan: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: Japan: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: India: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: India: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: South Korea: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: South Korea: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: Australia: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: Australia: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Indonesia: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Indonesia: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Others: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Others: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: Europe: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: Europe: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: Germany: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: Germany: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: France: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: France: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: United Kingdom: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: United Kingdom: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: Italy: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: Italy: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Spain: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Spain: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Russia: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 74: Russia: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Others: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 76: Others: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Latin America: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 78: Latin America: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: Brazil: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 80: Brazil: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Mexico: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 82: Mexico: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 83: Others: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 84: Others: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 85: Middle East and Africa: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
- Figure 86: Middle East and Africa: Anti-venom Market: Breakup by Country (in %), 2024
- Figure 87: Middle East and Africa: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 88: Global: Anti-venom Industry: SWOT Analysis
- Figure 89: Global: Anti-venom Industry: Value Chain Analysis
- Figure 90: Global: Anti-venom Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Anti-venom Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Anti-venom Market Forecast: Breakup by Species (in Million USD), 2025-2033
- Table 3: Global: Anti-venom Market Forecast: Breakup by Anti-venom Type (in Million USD), 2025-2033
- Table 4: Global: Anti-venom Market Forecast: Breakup by Mode of Action (in Million USD), 2025-2033
- Table 5: Global: Anti-venom Market Forecast: Breakup by End User (in Million USD), 2025-2033
- Table 6: Global: Anti-venom Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Anti-venom Market: Competitive Structure
- Table 8: Global: Anti-venom Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.